DE69028219T2 - Verwendung von honig als impfstoff - Google Patents

Verwendung von honig als impfstoff

Info

Publication number
DE69028219T2
DE69028219T2 DE69028219T DE69028219T DE69028219T2 DE 69028219 T2 DE69028219 T2 DE 69028219T2 DE 69028219 T DE69028219 T DE 69028219T DE 69028219 T DE69028219 T DE 69028219T DE 69028219 T2 DE69028219 T2 DE 69028219T2
Authority
DE
Germany
Prior art keywords
honey
milk
bird
cow
egg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028219T
Other languages
German (de)
English (en)
Other versions
DE69028219D1 (de
Inventor
Ralph J. Oregonia Oh 45054 Stolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Research and Development Corp
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Publication of DE69028219D1 publication Critical patent/DE69028219D1/de
Application granted granted Critical
Publication of DE69028219T2 publication Critical patent/DE69028219T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
DE69028219T 1989-11-06 1990-10-30 Verwendung von honig als impfstoff Expired - Fee Related DE69028219T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/431,639 US5130128A (en) 1982-06-03 1989-11-06 Use of honey as vaccine
PCT/US1990/006215 WO1991006321A1 (en) 1989-11-06 1990-10-30 Use of honey as vaccine

Publications (2)

Publication Number Publication Date
DE69028219D1 DE69028219D1 (de) 1996-09-26
DE69028219T2 true DE69028219T2 (de) 1997-03-27

Family

ID=23712804

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028219T Expired - Fee Related DE69028219T2 (de) 1989-11-06 1990-10-30 Verwendung von honig als impfstoff

Country Status (10)

Country Link
US (1) US5130128A (enExample)
EP (1) EP0593440B1 (enExample)
JP (1) JP2912451B2 (enExample)
AT (1) ATE141513T1 (enExample)
AU (1) AU644820B2 (enExample)
CA (1) CA2072658C (enExample)
DE (1) DE69028219T2 (enExample)
NZ (1) NZ235906A (enExample)
TW (1) TW210289B (enExample)
WO (1) WO1991006321A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054124A (en) * 1982-06-03 2000-04-25 Stolle Milk Biologics, Inc. Immune suppressive product
US5863561A (en) * 1982-06-03 1999-01-26 Stolle Research & Development Corporation Immune suppressive product
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
FR2796385A1 (fr) * 1999-07-16 2001-01-19 Inst Nat Sante Rech Med Methode de production d'anticorps dans le jaune d'oeuf et utilisation des anticorps ainsi obtenus
WO2001013928A1 (fr) * 1999-08-24 2001-03-01 Ortho Corporation Co., Ltd. Procedes de pasteurisation d'une substance immune contenant un facteur anti-inflammatoire et son utilisation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
AU2001249388A1 (en) 2000-03-24 2001-10-08 Trouw Nutrition Usa Combination of plasma and hyperimmunized products for increased performance

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
US3911108A (en) * 1973-02-14 1975-10-07 Diamond Shamrock Corp Process of producing bovine milk products containing specific antibodies
CH590064A5 (enExample) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4550019A (en) * 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
EP0225254B1 (en) * 1985-11-25 1994-03-16 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof

Also Published As

Publication number Publication date
JPH05501801A (ja) 1993-04-08
EP0593440A4 (en) 1992-12-30
CA2072658C (en) 2001-02-20
WO1991006321A1 (en) 1991-05-16
ATE141513T1 (de) 1996-09-15
US5130128A (en) 1992-07-14
DE69028219D1 (de) 1996-09-26
TW210289B (enExample) 1993-08-01
AU6614990A (en) 1991-05-31
EP0593440A1 (en) 1994-04-27
CA2072658A1 (en) 1991-05-07
NZ235906A (en) 1996-10-28
AU644820B2 (en) 1993-12-23
JP2912451B2 (ja) 1999-06-28
EP0593440B1 (en) 1996-08-21

Similar Documents

Publication Publication Date Title
DE3504221C2 (de) Mittel zur passiven Immunisierung von Säugern
DE3689717T2 (de) Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
DE3448494C2 (enExample)
DE69530588T2 (de) Cck-antikörper zur verbesserung der futterverwertung
DE2542792A1 (de) Verfahren zur erhoehung der antikoerpermenge in der milch von milchabsondernden rindern
DE1810438A1 (de) Prophylaktisches oder therapeutisches Praeparat
DE68923310T2 (de) Antientzündungsfaktor aus Milch.
CH651210A5 (de) Verfahren zur herstellung einer antikoerper enthaltenden milch zur bekaempfung bakterieller infektionen des magen-darm-traktes.
DE69737191T2 (de) Entzündungshemmende Zusammensetzung aus Ei, Verfahren zur Isolierung und Verwendung
DE69130323T2 (de) Entzündungshemmender faktor, verfahren zur isolation und verwendung
DE60124591T2 (de) Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung
DE60216906T2 (de) Anti-pilyrosporum ovale igy und dessen verwendung
US5130128A (en) Use of honey as vaccine
DE69022980T2 (de) Gesteigerte erzeugung von proteinen in tieren.
DE602004005963T2 (de) Verwendung von vogelantikörpern
AU2004212980B2 (en) Immunogene adherence and method of making and using same
El-Yazeed et al. Trials for reducing aflatoxin B1 residues in chicken meat and eggs using a newly developed aflatoxin B1 vaccine
DE1792256C3 (de) Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
DE3878982T2 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
DE19910159A1 (de) Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung
DE69331836T2 (de) Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung
DE60025945T2 (de) Herstellung von antikörpern in mammarsekreten von zuchttieren
DE2034118A1 (en) Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
DE60006693T2 (de) Glukosamin und hyperimmunes Ei zur Verminderung von Entzündungen
DE2045160B2 (de) Verfahren zur Herstellung einer Lebendvaccine gegen die infektiöse Bursitis der Hühner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee